RAC 0.00% $1.69 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 219 Posts.
    lightbulb Created with Sketch. 73
    The ducks are all lining up. Bisantrene’s potential to change the oncology landscape for the better is becoming more real everyday. Fantastic news as always Race. Well done team.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.